General Information of the Compound
| Compound ID |
CP0253784
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[3-fluoro-4-[2-[4-(piperazin-1-ylmethyl)phenyl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-2-oxo-3-phenylimidazolidine-1-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H31FN6O3S
|
||||||||||||||||||
| Molecular Weight |
622.726
|
||||||||||||||||||
| Canonical SMILES |
Fc1cc(NC(=O)N2CCN(C2=O)c2ccccc2)ccc1Oc1ccnc2cc(sc12)-c1ccc(CN2CCNCC2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H31FN6O3S/c35-27-20-25(38-33(42)41-19-18-40(34(41)43)26-4-2-1-3-5-26)10-11-29(27)44-30-12-13-37-28-21-31(45-32(28)30)24-8-6-23(7-9-24)22-39-16-14-36-15-17-39/h1-13,20-21,36H,14-19,22H2,(H,38,42)
Show/Hide
|
||||||||||||||||||
| InChIKey |
KPPTZOUOPSHOGH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01201, Hepatocyte growth factor receptor
Protein ID: PT00864, Vascular endothelial growth factor receptor 2